Current Drug Targets
Volume 21, 16 Issues, 2020
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Drug Targets, Volume 8 - Number 12
Oxidative Stress as a Regulator of Murine Atherosclerosis
, 8(12): 1222 - 1229Tzung Hsiai and Judith A. Berliner
DOI: 10.2174/138945007783220678
The Toll of Toll-Like Receptors, Especially Toll-Like Receptor 2, on Murine Atherosclerosis
, 8(12): 1230 - 1238L. K. Curtiss and P. S. Tobias
DOI: 10.2174/138945007783220605
Leukocyte Influx in Atherosclerosis
, 8(12): 1239 - 1248Elena Galkina and Klaus Ley
DOI: 10.2174/138945007783220650
Macrophage-Derived Foam Cells in Atherosclerosis: Lessons from Murine Models and Implications for Therapy
, 8(12): 1249 - 1263Nancy R. Webb and Kathryn J. Moore
DOI: 10.2174/138945007783220597
Cytokines as Regulators of Atherosclerosis in Murine Models
, 8(12): 1264 - 1272Ziad Mallat and Alain Tedgui
DOI: 10.2174/138945007783220588
The Immune System and Murine Atherosclerosis
, 8(12): 1297 - 1306Godfrey S. Getz, Paul A. VanderLaan and Catherine A. Reardon
DOI: 10.2174/138945007783220669
Lipases as Modulators of Atherosclerosis in Murine Models
, 8(12): 1307 - 1319Robert J. Brown and Daniel J. Rader
DOI: 10.2174/138945007783220614
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63
Advertisement
Webmaster Contact: info@benthamscience.net